Ingenix, a health information, technology, consulting and services company, announced that it has expanded its health outcomes measurement capabilities with the acquisition of QualityMetric Incorporated. QualityMetric helps health care companies assess health outcomes as reported by patients themselves, known as patient-reported outcomes.
This acquisition adds a new dimension to the capabilities Ingenix can offer to life sciences companies, governments, health systems, payers and consumers. Patient-reported outcomes (PROs) are an important measure of the ultimate effectiveness of health care. QualityMetric develops and maintains popular general and disease-specific health surveys for measuring patients’ own assessments of their health.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.